| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.00044 | 1 |